Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models

NeuroImage: Clinical

Volumn 8, Issue , 2015, Pages 606-610

  Chua, Alicia S ^a   Egorova, Svetlana ^a,b   Anderson, Mark C ^a   Polgar Turcsanyi, Mariann ^a   Chitnis, Tanuja ^a,b   Weiner, Howard L ^a,b   Guttmann, Charles R G ^a   Bakshi, Rohit ^a,b   Healy, Brian C ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain atrophy; Mixed effect models; MRI; Multiple sclerosis; T2 lesion

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN PARENCHYMAL FRACTION; COHORT ANALYSIS; COMPARATIVE STUDY; DEMYELINATING DISEASE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; HYPERINTENSE LESION VOLUME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL MODEL; TUMOR VOLUME; ATROPHY; BRAIN; PATHOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADULT; ATROPHY; BRAIN; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MODELS, STATISTICAL; MULTIPLE SCLEROSIS;

EID: 84934766355     PISSN: None     EISSN: 22131582     Source Type: Journal    
DOI: 10.1016/j.nicl.2015.06.009     Document Type: Article

References (26)

1. Anderson V.M., Bartlett J.W., Fox N.C., Fisniku L., and Miller D.H. Detecting treatment effects on brain atrophy in relapsing remitting multiple sclerosis: sample size estimates J. Neurol. 254 11 2007 1588 1594 10.1007/s00415-007-0599-3 17940723
2. Bermel R.A., and Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis Lancet Neurol. 5 2 2006 158 170 10.1016/S1474-4422(06)70349-0 16426992
3. Bernal-Rusiel J.L., Greve D.N., Reuter M., Fischl B., Sabuncu M.R. Alzheimer's Disease Neuroimaging Initiative Statistical analysis of longitudinal neuroimage data with linear mixed effects models Neuroimage 66 2013 249 260 10.1016/j.neuroimage.2012.10.065 23123680
4. Bowman F.D. Brain imaging analysis Annual Review of Statistics and its Application 1 2014 61 85 10.1146/annurev-statistics-022513-115611 25309940
5. Dell'Oglio E., Ceccarelli A., Glanz B.I., Healy B.C., Tauhid S., Arora A., and Neema M. Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors J. Neuroimag. 25 2 2015 191 199 10.1111/jon.12194 25523616
6. Diggle P.J., Heagerty P., Liang K.-Y., and Zeger S. Analysis of longitudinal data 2002 Oxford University Press
7. Filippi M., Dousset V., McFarland H.F., Miller D.H., and Grossman R.I. Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group J. Magn. Reson. Imaging 15 5 2002 499 504 11997889
8. Fisher E., Rudick R.A., Simon J.H., Cutter G., Baier M., Lee J.C., and Simonian N.A. Eight-year follow-up study of brain atrophy in patients with MS Neurology 59 9 2002 1412 1420 10.1212/01.WNL.0000036271.49066.06 12427893
9. Fitzmaurice G.M., Laird N.M., and Ware J.H. Applied Longitudinal Analysis 998 2012 John Wiley & Sons
10. Gauthier S.A., Glanz B.I., Mandel M., and Weiner H.L. A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study Autoimmun. Rev. 5 8 2006 532 536 10.1016/j.autrev.2006.02.012 17027888
11. Jones B.C., Nair G., Shea C.D., Crainiceanu C.M., Cortese I.C., and Reich D.S. Quantification of multiple-sclerosis-related brain atrophy in two heterogeneous MRI datasets using mixed-effects modeling Neuroimage Clin. 3 2013 171 179 24179861
12. Kikinis R., Shenton M.E., Gerig G., Martin J., Anderson M., Metcalf D., and Lorensen W. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging J. Magn. Reson. Imaging 2 6 1992 619 629 10.1002/jmri.1880020603 1446105
13. Krupp L.B., LaRocca N.G., Muir-Nash J., and Steinberg A.D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus Arch. Neurol. 46 10 1989 1121 1123 10.1001/archneur.1989.00520460115022 2803071
14. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 11 1983 1444 1452 10.1212/WNL.33.11.1444 6685237
15. Lange N. Statistical procedures for functional MRI Functional M.R.I. 1999 301 335
16. Liguori M., Healy B.C., Glanz B.I., Khoury S.J., Moscufo N., Weiner H.L., and Guttmann C.R. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study Genes Immun. 12 3 2011 183 190 10.1038/gene.2010.58 21179117
17. Liu L., Meier D., Polgar-Turcsanyi M., Karkocha P., Bakshi R., and Guttmann C.R. Multiple sclerosis medical image analysis and information management J. Neuroimag. 15 4 Suppl 2005 103S 117S 10.1177/1051228405282864 16385023
18. Miller D.H., Grossman R.I., Reingold S.C., and McFarland H.F. The role of magnetic resonance techniques in understanding and managing multiple sclerosis Brain 121 1 1998 3 24 10.1093/brain/121.1.3 9549485
19. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., and Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald criteria" Ann. Neurol. 58 6 2005 840 846 10.1002/ana.20703 16283615
20. Rao S.M., Leo G.J., Bernardin L., and Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction Neurology 41 5 1991 685 691 10.1212/WNL.41.5.685 2027484
21. Rudick R.A., Fisher E., Lee J.C., Duda J.T., and Simon J. Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a Mult. Scler. 6 6 2000 365 372 11212130
22. Steinman L. Multiple sclerosis: a two-stage disease Nat. Immunol. 2 9 2001 762 764 10.1038/ni0901-762 11526378
23. Verbeke G., and Molenberghs G. Linear Mixed Models for Longitudinal Data 2009 Springer
24. Wei X., Guttmann C.R., Warfield S.K., Eliasziw M., and Mitchell J.R. Has your patient's multiple sclerosis lesion burden or brain atrophy actually changed? Mult. Scler. 10 4 2004 402 406 10.1191/1352458504ms1061oa 15327037
25. Wei X., Warfield S.K., Zou K.H., Wu Y., Li X., Guimond A., and Guttmann C.R. Quantitative analysis of MRI signal abnormalities of brain white matter with high reproducibility and accuracy J. Magn. Reson. Imaging 15 2 2002 203 209 10.1002/jmri.10053 11836778
26. Zivadinov R., Locatelli L., Cookfair D., Srinivasaraghavan B., Bertolotto A., Ukmar M., and Zorzon M. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy Mult. Scler. 13 4 2007 490 501 10.1177/1352458506070446 17463072